La catena delle opzioni mostra i dati chiave delle opzioni azionarie di ACNB a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per ACNB..

ACNB (NASDAQ:ACNB) Azioni, Catena delle Opzioni

ACNB

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

ACNB Corp

ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.93 by 10.75 percent. This is a 28.75 percent increase over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $34.27 million which beat the analyst consensus estimate of $32.65 million by 4.96 percent. This is a 30.52 percent increase over sales of $26.26 million the same period last year.

Earnings

Earnings Beats

News

ACNB Q1 Adj. EPS $1.03 Beats $0.93 Estimate, Sales $34.27M Beat $32.65M Estimate

ACNB Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that the Board of Directors approved and declared a regular quarterly cash dividend of $0.34 per share of ACNB Corporation common stock payable on June 13, 2025, to shareholders of record as of May 30, 2025. This per share amount reflects a 6.25% increase over the $0.32 per share paid in the first quarter of 2025.

Dividends

ACNB Raises Quarterly Dividend From $0.32 To $0.34 Per Share

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs analyst James Quigley initiated coverage on Sanofi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) with a Neutral rating and announced a price target of $65. Sanofi shares closed at $57.79 on Thursday. <a href="https://www.benzinga.com/quote/SNY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Daniel Tamayo initiated coverage on ACNB Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with an Outperform rating and announced a price target of $47. ACNB shares closed at $41.25 on Thursday. <a href="https://www.benzinga.com/quote/ACNB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities analyst Nick Giles initiated coverage on United States Antimony Corporation (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#AMEX">UAMY</a>) with a Buy rating and announced a price target of $3. United States Antimony shares closed at $1.79 on Thursday. <a href="https://www.benzinga.com/quote/UAMY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Jason McCarthy initiated coverage on Anixa Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIX#NASDAQ">ANIX</a>) with a Buy rating and announced a price target of $1. Anixa Biosciences shares closed at $3.15 on Thursday. <a href="https://www.benzinga.com/quote/ANIX/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ACNB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="587" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091039/image-197-1024x587.png" alt="" class="wp-image-835923" style="width:467px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091039/image-197-1024x587.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091039/image-197-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091039/image-197-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091039/image-197.png 1085w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/03/44414749/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-march">Top 2 Defensive Stocks That May Keep You Up At Night In March</a></li>
</ul>

Photo: Shutterstock

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ANIX

UAMY

This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Raymond James analyst Daniel Tamayo initiates coverage on ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Outperform rating and announces Price Target of $47.

Price Target

Raymond James Initiates Coverage On ACNB with Outperform Rating, Announces Price Target of $47

Piper Sandler analyst Justin Crowley upgrades ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) from Neutral to Overweight and raises the price target from $37 to $50.

Upgrades

Piper Sandler Upgrades ACNB to Overweight, Raises Price Target to $50

Earnings Misses

ACNB Q4 2024 GAAP EPS $0.77 Misses $0.84 Estimate

ACNB Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) ("ACNB"), the parent financial holding company of ACNB Bank, a Pennsylvania state-chartered, FDIC insured community bank headquartered in Gettysburg, PA and Traditions Bancorp, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TRBK#OTC">TRBK</a>) ("Traditions") and its wholly-owned subsidiary, Traditions Bank, headquartered in York, PA are pleased to announce the receipt of each of their respective shareholder approvals for ACNB's proposed acquisition of Traditions.

TRBK

ACNB Corp And Traditions Bancorp Announce Receipt Of Shareholder Approvals For Acquisition

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6054966d36622a00019eaa50/peter-low">Redburn Atlantic analyst Peter Low</a> upgraded the rating for Equinor ASA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) from Neutral to Buy. Equinor shares closed at $23.67 on Tuesday. <a href="https://www.benzinga.com/quote/EQNR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies analyst Greg Konrad upgraded AeroVironment, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) from Hold to Buy but lowered the price target from $240 to $230. AeroVironment shares closed at $194.89 on Tuesday. <a href="https://www.benzinga.com/quote/AVAV/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e5520feece4e60001201237/andrea-teixeira">JP Morgan analyst Andrea Teixeira</a> upgraded the rating for Energizer Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) from Underweight to Neutral and raised the price target from $32 to $39. Energizer shares closed at $37.25 on Tuesday. <a href="https://www.benzinga.com/quote/ENR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Matthew Weston upgraded the rating for AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) from Sell to Neutral. AstraZeneca shares closed at $63.80 on Tuesday. <a href="https://www.benzinga.com/quote/AZN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities analyst Curtis Nagle upgraded Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) from Underperform to Buy and raised the price target from $24 to $40. Chewy shares closed at $32.94 on Tuesday. <a href="https://www.benzinga.com/quote/chwy/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying AZN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20072541/image-206-1024x572.png" alt="" class="wp-image-656781" style="width:653px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20072541/image-206-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20072541/image-206-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20072541/image-206-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20072541/image-206.png 1177w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42069785/wall-streets-most-accurate-analysts-weigh-in-on-3-defensive-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields</a></li>
</ul>

AVAV

CHWY

EQNR

This AstraZeneca Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/607ebdb217ff280001130e2a/julian-harrison">BTIG analyst Julian Harrison</a> upgraded the rating for Aclaris Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) from Neutral to Buy and announced a price target of $8. Aclaris Therapeutics shares closed at $3.14 on Monday. <a href="https://www.benzinga.com/quote/ACRS/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/650428998345120001a2f3ec/wesley-brooks">HSBC analyst Wesley Brooks</a> upgraded the rating for QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) from Reduce to Hold and announced a price target of $5.3. QuantumScape shares closed at $4.73 on Monday. <a href="https://www.benzinga.com/quote/QS/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5809e400846faa000106ad3a/cory-kasimov">Evercore ISI Group analyst Cory Kasimov</a> upgraded the rating for BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) from In-Line to Outperform and boosted the price target from $110 to $125. BioNTech shares closed at $101.87 on Monday. <a href="https://www.benzinga.com/quote/BNTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity analyst Matthew Lee upgraded Bank of Nova Scotia (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BNS#TSX">BNS</a>) from Hold to Buy and raised the price target from C$71 to C$84. <a href="https://www.benzinga.com/quote/BNS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies analyst Roger Song upgraded the rating for Aclaris Therapeutics, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) from Hold to Buy and raised the price target from $2 to $7. Aclaris Therapeutics shares closed at $3.14 on Monday. <a href="https://www.benzinga.com/quote/acrs/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying BNTX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="559" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073934/image-195-1024x559.png" alt="" class="wp-image-654905" style="width:678px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073934/image-195-1024x559.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073934/image-195-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073934/image-195-768x419.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073934/image-195.png 1205w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42035732/jim-cramer-super-group-basic-materials-stock-is-very-hard-to-own-here">Jim Cramer: Super Group Finally &#8216;Broke Out,&#8217; This Basic Materials Stock Is &#8216;Very Hard To Own Here&#8217;</a></li>
</ul>

ACHR

ACRS

BNTX

TSX:BNS

This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Bernstein analyst Alex Irving downgraded the rating for Sabre Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABR#NASDAQ">SABR</a>) from Market Perform to Underperform and announced a $3 price target. Sabre shares closed at $3.79 on Monday. <a href="https://www.benzinga.com/quote/SABR/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/580ded6b846faa000106aeb1/michael-lavery">Piper Sandler analyst Michael Lavery</a> downgraded The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) from Overweight to Neutral and lowered the price target from $40 to $35. Kraft Heinz shares closed at $31.07 on Monday. <a href="https://www.benzinga.com/quote/KHC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Phillip Securities analyst Helena Wang downgraded the rating for Sea Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) from Neutral to Reduce but raised the price target from $80 to $100. Septerna shares closed at $108.63 on Monday. <a href="https://www.benzinga.com/quote/SE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Joseph Civello downgraded Academy Sports and Outdoors, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) from Buy to Hold and lowered the price target from&nbsp;$63&nbsp;to&nbsp;$50. Academy Sports shares closed at $46.60 on Monday. <a href="https://www.benzinga.com/quote/aso/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS analyst Alberto Valerio downgraded the rating for Embraer S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERJ#NYSE">ERJ</a>) from Neutral to Sell and raised the price target from $29 to $32. Embraer shares closed at $38.81 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying KHC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="497" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073339/image-194-1024x497.png" alt="" class="wp-image-654884" style="width:704px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073339/image-194-1024x497.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073339/image-194-300x146.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073339/image-194-768x373.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19073339/image-194.png 1301w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42035732/jim-cramer-super-group-basic-materials-stock-is-very-hard-to-own-here">Jim Cramer: Super Group Finally &#8216;Broke Out,&#8217; This Basic Materials Stock Is &#8216;Very Hard To Own Here&#8217;</a></li>
</ul>

Downgrades

Embraer-Empresa Brasileira De Aeronautica

SABR

This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/607595562290f100012ab4ae/tim-hsiao">Morgan Stanley analyst Tim Hsiao</a> initiated coverage on WeRide Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) with an Overweight rating and announced a price target of $23. WeRide shares closed at $18.33 on Monday. <a href="https://www.benzinga.com/quote/WRD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler analyst John Barnidge initiated coverage on Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) with an Overweight rating and announced a price target of $188. Apollo Global Management shares closed at $164.31 on Monday. <a href="https://www.benzinga.com/quote/APO/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/602e9a6a5864de000147ed6f/yaron-werber">TD Cowen analyst Yaron Werber </a>initiated coverage on Septerna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) with a Buy rating. Septerna shares closed at $23.55 on Monday. <a href="https://www.benzinga.com/quote/SEPN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst Chris Pierce initiated coverage on Archer Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) with a Buy rating and announced a price target of $11. Archer Aviation shares closed at $4.41 on Monday. <a href="https://www.benzinga.com/quote/ACHR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Janney Montgomery Scott analyst Daniel Cardenas initiated coverage on ACNB Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Buy rating and announced a price target of $53. ACNB shares closed at $46.35 on Monday. <a href="https://www.benzinga.com/quote/ACNB/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying APO stock? Here&#8217;s what analysts think :
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19072545/image-193-1024x547.png" alt="" class="wp-image-654858" style="width:711px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19072545/image-193-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19072545/image-193-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19072545/image-193-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/19072545/image-193.png 1183w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42035732/jim-cramer-super-group-basic-materials-stock-is-very-hard-to-own-here">Jim Cramer: Super Group Finally &#8216;Broke Out,&#8217; This Basic Materials Stock Is &#8216;Very Hard To Own Here&#8217;</a></li>
</ul>

SEPN

This Apollo Global Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Janney Montgomery Scott analyst Daniel Cardenas initiates coverage on ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Buy rating and announces Price Target of $53.

Janney Montgomery Scott Initiates Coverage On ACNB with Buy Rating, Announces Price Target of $53

Government

Regulations

Legal

ACNB Corporation Receives All Required Regulatory Approvals To Acquire Traditions Bancorp

WIIM

ABCB

AMAL

AMTB

AROW

BANF

BANR

BCAL

BFST

BHLB

BHRB

BMRC

BOKF

BPOP

BRKL

BSRR

BSVN

BUSE

CARE

CASH

CATY

CBAN

CBNK

CBSH

CCBG

CCNE

CFFN

CHCO

CLBK

CNOB

COFS

CTBI

CUBI

CVBF

CZFS

DCOM

EBTC

EFSC

EGBN

EQBK

EWBC

FBIZ

FBMS

FBNC

FCBC

FCNCA

FFBC

FFIC

FFIN

FFWM

FIBK

FISI

FLIC

FMAO

FMBH

FMNB

FNLC

FRBA

FRME

FRST

FSBC

GABC

GBCI

GCBC

GNTY

GSBC

HAFC

HBCP

HBNC

HFBL

HFWA

HIFS

HMST

HOMB

HONE

HOPE

HTBI

HTBK

HTLF

Shares of banking-related companies are trading higher after Donald Trump won the US presidential election.

ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) reported quarterly earnings of $0.84 per share which missed the analyst consensus estimate of $0.86 by 2.33 percent. This is a 20.75 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $27.75 million which beat the analyst consensus estimate of $27.28 million by 1.71 percent. This is a 1.05 percent decrease over sales of $28.04 million the same period last year.

ACNB Q3 EPS $0.84 Misses $0.86 Estimate, Sales $27.75M Beat $27.28M Estimate

Hovde Group analyst David Bishop upgrades ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) from Market Perform to Outperform.

Hovde Group Upgrades ACNB to Outperform

Piper Sandler analyst Justin Crowley maintains ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Neutral and lowers the price target from $40 to $37.

Piper Sandler Maintains Neutral on ACNB, Lowers Price Target to $37

ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) reported quarterly earnings of $0.80 per share which met the analyst consensus estimate.

ACNB Q1 2024 GAAP EPS $0.80, Inline

ACNB Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that the Board of Directors approved and declared a regular quarterly cash dividend of $0.32 per share of ACNB Corporation common stock payable on June 14, 2024, to shareholders of record as of May 31, 2024. This per share amount reflects a 14.2% increase over the $0.28 per share paid in the second quarter of 2023, and a 6.6% increase over the $0.30 per share paid in the first quarter of 2024. This dividend declaration will result in aggregate dividend payments of approximately $2.72 million to ACNB Corporation shareholders in the second quarter of 2024. &nbsp;
"I am pleased to announce this increase in ACNB Corporation's quarterly dividend, which reflects our Board of Directors' longstanding commitment to delivering value to shareholders in the form of quarterly cash dividend payments," said James P. Helt, ACNB Corporation President &amp; Chief Executive Officer. Mr. Helt continued, "Our decision to increase the dividend is a testament to the strength of our financial position and our confidence in the future growth and profitability of ACNB Corporation. This dividend declaration also represents our second increase to the quarterly cash dividend in less than a year, and represents the fourth consecutive calendar year the Corporation has increased the quarterly cash dividend."

ACNB Corporation Announces Increase In Quarterly Cash Dividend From $0.30 To $0.32 Per Share

Offerings

ACNB Corp Files For Mixed Shelf Of Upto $100M

Press Releases

ACNB Corporation Receives Regulatory Approvals to Acquire Traditions Bancorp, Inc.

ACNB INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ACNB Corporation - ACNB

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, ACNB, PIRS, OBDE on Behalf of Shareholders

ACNB Corporation and Traditions Bancorp, Inc.  Announce Receipt of Shareholder Approvals for Acquisition

ACNB Corporation Reports Fourth Quarter and 2024 Financial Results

ACNB Corporation Announces First Quarter Cash Dividend

ACNB Corporation Announces Completion of Traditions Bancorp, Inc. Acquisition

CORRECTION - ACNB Corporation Announces Completion of Traditions Bancorp, Inc. Acquisition

Comments

ACNB

ACNB (ACNB) Opzioni

ACNB (NASDAQ:ACNB) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO